[ Price : $8.95]
Arrowhead Pharmaceuticals agrees to acquire an FDA Rare Pediatric Disease Priority Review Voucher from an undisclosed third party ...[ Price : $8.95]
Four stakeholders praise an FDA draft guidance on streamlining some oncology nonclinical safety studies and recommend improvements...[ Price : $8.95]
FDA warns Dabur India Limited about CGMP violations in its production of finished drugs.[ Price : $8.95]
FDA warns St. Louis, MO-based Koven Technologies about QSMR issues in its manufacturing and marketing of the Bidop 3 Doppler.[ Price : $8.95]
FDA undertakes a broad modernization of its inspection program, including expanded use of risk-based oversight, greater reliance o...[ Price : $8.95]
FDA issues an updated final guidance entitled Applying Human Factors and Usability Engineering to Medical Devices.[ Price : $8.95]
FDA grants Eli Lilly a breakthrough therapy designation for olomorasib as a monotherapy for treating adult patients with advanced ...[ Price : $8.95]
Sandoz reaches agreements totaling about $479 million to resolve most of its remaining exposure in long-running U.S. litigation al...